**HIV Overview**
- **Type**: RNA retrovirus
- **Target Cells**: CD4+ T cells, macrophages
- **Progression**: Leads to AIDS in ~10 years
- **Impact**: Increases susceptibility to opportunistic infections, major global health issue

---

### Diagnosis

**Modes of Transmission**:
- **Horizontal**:
  - Unprotected sexual intercourse (homo/heterosexual)
  - Blood transfusion
  - IVDU
  - Needlestick injuries
- **Vertical**:
  - Pregnancy, delivery, breastfeeding

**WHO Classification in Adults**:
1. **Primary Infection**: Asymptomatic or acute retroviral syndrome
2. **Asymptomatic**: Persistent generalized lymphadenopathy
3. **Mildly Symptomatic**:
   - Weight loss (<10%)
   - Recurrent respiratory infections
   - Herpes zoster
   - Oral ulcers
4. **Moderately Symptomatic**:
   - Weight loss (>10%) / diarrhea / persistent fever
   - Tuberculosis (TB)
   - Oral candidiasis
   - Severe bacterial infections
   - Unexplained anemia, neutropenia, thrombocytopenia
5. **Severely Symptomatic (AIDS)**:
   - HIV wasting syndrome
   - Pneumocystis pneumonia
   - Oesophageal/pulmonary candidiasis
   - Kaposiâ€™s sarcoma
   - Mycobacterium avium complex
   - CMV retinitis

**Clinical Findings in Infants**:
- Failure to thrive
- Possible AIDS-defining illnesses

---

### Investigations

**Diagnosis Tests**:
- **ELISA**: Confirm with 2nd ELISA/Western blot
- **Rapid Test**: Confirm with 2nd rapid test
- **DNA PCR**: Mainly for infants
- **Serum p24 Antigen**
- **Buccal Saliva Tests**: for surveillance

**Monitoring Tests**:
- **CD4 Count**:
  - >500: Asymptomatic
  - <350: Significant immunosuppression
  - <200: AIDS
- **Viral Load**:
  - >1000 copies/mL: Confirms acute infection

**Additional Tests**: 
- Drug resistance testing 
- Contextual tests (pregnancy, hepatitis, venereal diseases)

---

### Management

**Emergency Management**:
- Mandatory referral to an HIV specialist for suspected cases
- Life-threatening AIDS illnesses warrant secondary care referral

**Specific Conditions**:
1. **Pneumocystis Pneumonia**:
   - Symptoms: Fever, dyspnoea, cough
   - Treatment: High-dose co-trimoxazole
2. **Cryptococcal Meningitis**:
   - Symptoms: Headache, confusion, neck pain, fever
   - Treatment: Amphotericin B + flucytosine, then fluconazole
3. **Cerebral Toxoplasmosis**:
   - Symptoms: Focal neurology, encephalitis
   - Treatment: Pyrimethamine + sulfadiazine + calcium folinate

---

### ART Prescribing

- **Initiate treatment at diagnosis, regardless of lab results**.
- **Backbone Regimen**: 2 NRTIs + 1 additional medication (NNRTI, INI, or PI).

**Possible Regimens**:
- **Backbone Examples**:
  - Emtricitabine + tenofovir disoproxil
  - Emtricitabine + tenofovir alafenamide
  - Abacavir + lamivudine
- **3rd Medication Options**:
  - NNRTI: Efavirenz, rilpivirine
  - INI: Dolutegravir, raltegravir
  - PI: Boosted atazanavir/darunavir

**Pregnancy Management**: 
- **Pre-existing**: Continue ART
- **New diagnosis**: Use specific backbone medications and prefer early viral suppression.

**Post-Exposure Prophylaxis**: 
- 28-day course of emtricitabine + tenofovir disoproxil + raltegravir.

---

### Non-Prescribing Management

- **Comprehensive Counselling**: Address sexual, reproductive, mental health
- **Adherence Support**: Prevent disease progression and resistance by ensuring compliance to treatment.

---

### References

- BMJ Best Practice
- BNF 
- NICE CKS 
- WHO Clinical Staging Guidelines